TB-500, a synthetic fragment of thymosin beta-4 originating from thymus peptide research of the 1960s, has been examined in studies of angiogenesis and cellular migration
Early clinical trials highlight common side effects such as mild nausea, vomiting, and diarrhea
This peptide was exendin-4 , and it would become the foundation of the first GLP-1 drug (details in the next section)
Pharma has been a defensive haven in 2026 as tech rotates out, but sentiment is shifting
A Healthy Connections provider can review BMI, health conditions, medication history, previous treatment efforts, and the potential benefits and risks of GLP-1 therapy
Prevention and Future Research Preventing NAION and other severe side effects in patients taking semaglutide requires a collaborative approach between patients and healthcare professionals